Fanny Tzelepis
Ottawa, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Oncolytic Rhabdovirus Vaccine Boosts Chimeric Anti-DEC205 Priming for Effective Cancer Immunotherapy.
Journal: Molecular therapy oncolytics
Published: January 15, 2020
The strategic combination of trastuzumab emtansine with oncolytic rhabdoviruses leads to therapeutic synergy.
Journal: Communications biology
Published: September 05, 2019
Transforming the prostatic tumor microenvironment with oncolytic virotherapy.
Journal: Oncoimmunology
Published: February 20, 2018
Mitochondrial cyclophilin D regulates T cell metabolic responses and disease tolerance to tuberculosis.
Journal: Science immunology
Published: November 06, 2017
Multi-modal Potentiation of Oncolytic Virotherapy by Vanadium Compounds.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: June 23, 2017
Oncolytic Maraba Virus MG1 as a Treatment for Sarcoma.
Journal: International journal of cancer
Published: May 03, 2017
BCG Educates Hematopoietic Stem Cells to Generate Protective Innate Immunity against Tuberculosis.
Journal: Cell
Published: April 24, 2017
Bcl-xL mediates RIPK3-dependent necrosis in M. tuberculosis-infected macrophages.
Journal: Mucosal immunology
Published: May 05, 2016
Annexin1 regulates DC efferocytosis and cross-presentation during Mycobacterium tuberculosis infection.
Journal: The Journal of clinical investigation
Published: May 23, 2014
NLRX1 prevents mitochondrial induced apoptosis and enhances macrophage antiviral immunity by interacting with influenza virus PB1-F2 protein.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: May 07, 2014
Targeted prostaglandin E2 inhibition enhances antiviral immunity through induction of type I interferon and apoptosis in macrophages.
Journal: Immunity
Published: October 24, 2013
Last Updated: 09/26/2026